Brief: GreenLight Biosciences agrees to go public in $1.2bn SPAC merger
The ag biotech company, which uses the RNA tech made famous by Covid-19 vaccines, will list on the Nasdaq – eventually providing an exit for investors including AgFunder, S2G Ventures, and Continental Grain Company.
Sponsored
International Fresh Produce Association launches year 3 of its produce accelerator